Wambolt & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Buy |
478
+13
| +3% | +$10.1K | 0.12% | 132 |
|
|
2025
Q1 | $374K | Sell |
465
-21
| -4% | -$16.9K | 0.13% | 127 |
|
|
2024
Q4 | $376K | Sell |
486
-1,330
| -73% | -$1.03M | 0.12% | 135 |
|
|
2024
Q3 | $1.61M | Buy |
1,816
+9
| +0.5% | +$7.96K | 0.44% | 72 |
|
|
2024
Q2 | $1.65M | Hold |
1,807
| – | – | 0.48% | 69 |
|
|
2024
Q1 | $1.37M | Buy |
1,807
+449
| +33% | +$341K | 0.41% | 76 |
|
|
2023
Q4 | $791K | Sell |
1,358
-154
| -10% | -$89.8K | 0.26% | 121 |
|
|
2023
Q3 | $814K | Buy |
1,512
+137
| +10% | +$73.7K | 0.3% | 120 |
|
|
2023
Q2 | $645K | Buy |
1,375
+25
| +2% | +$11.7K | 0.23% | 138 |
|
|
2023
Q1 | $473K | Hold |
1,350
| – | – | 0.17% | 169 |
|
|
2022
Q4 | $494K | Buy |
1,350
+143
| +12% | +$52.3K | 0.19% | 151 |
|
|
2022
Q3 | $390K | Sell |
1,207
-50
| -4% | -$16.2K | 0.17% | 163 |
|
|
2022
Q2 | $407K | Sell |
1,257
-3
| -0.2% | -$971 | 0.16% | 166 |
|
|
2022
Q1 | $369K | Buy |
1,260
+91
| +8% | +$26.7K | 0.13% | 176 |
|
|
2021
Q4 | $323K | Buy |
1,169
+3
| +0.3% | +$829 | 0.12% | 196 |
|
|
2021
Q3 | $268K | Hold |
1,166
| – | – | 0.11% | 206 |
|
|
2021
Q2 | $269K | Buy |
+1,166
| New | +$269K | 0.11% | 209 |
|